Nurse-led eye injections: a new care approach
Part of Eyes & vision, Heart & circulation clinical trials.
This trial tests whether specially trained nurses can safely give eye injections instead of doctors. It may make treatment quicker and easier for people who need regular injections for eye conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You need eye injections (intravitreal therapy) for an eye condition.
- You are able to stay still and cooperate during the injection.
- You have not had an eye infection (like pink eye or discharge) in the last 15 days.
- You have not had a heart attack or stroke in the last 3 months.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways to keep the eye open during injections for conditions like wet macular degeneration. It tests a new method using a cotton-tipped applicator instead of a speculum to see if it is less painful and just as safe.
This study tests whether a coordinated team approach can help patients stick with regular eye injections for conditions like age-related macular degeneration and diabetic eye disease. Researchers want to see if extra support and planning improve how often patients complete their recommended treatments.
This study tests a new drug (RO7823653) given as an eye injection for people with diabetic macular edema, a condition where swelling in the retina harms vision. It aims to see if the drug is safe and how the body processes it.
This Phase 3 study compares a new eye injection (RC28-E) with the standard treatment (aflibercept) for diabetic macular edema, which is swelling in the central retina that affects vision. It aims to see whether the new treatment works as well and is safe.
This study compares two different eye injection treatments for diabetic macular edema (DME)—a condition where fluid builds up in the center of the retina, blurring vision. Researchers want to see how certain measures in the blood and in eye scans relate to how well each treatment works.
This study tests whether receiving anti-VEGF injections for diabetic macular edema (DME) at home is as safe and effective as getting them in the hospital. You would use a home device to check your vision and eye scans, and a nurse would visit for injections.
Hear when a new Macular Edema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.